/pdf/2021-esc-guidelines-on-cardiac-pacing-and-cardiac-kz0aans6lp.pdf

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000628

2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyDeveloped by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)

A Novel Pacing Strategy With Low and Stable Output: Pacing the Left Bundle Branch Immediately Beyond the Conduction Block

Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: A multicenter experience

https://www.heartrhythmjournal.com/article/S1547-5271(15)00347-1/pdf

His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison.

Patients and clinicians want to know who is protected from SARS-CoV-2 infection. This update is part of a living systematic review to understand the potential value of antibody testing as a correlate of protection against infection. Because the previous review found that seroconversion was a near-universal consequence of recent infection in immunocompetent patients, this review examines the risk for reinfection in adults after SARS-CoV-2 infection, whether diagnosed by polymerase chain reaction test, antibody test, or a combination of both.

Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection

What is the risk of reinfection from SARS-CoV-2 among adults with prior SARS-CoV-2 Title and abstract screening was completed by a single screener and exclusion decisions confirmed by a second screener. Full-text screening was completed by two reviewers and any conflicts resolved by a third independent reviewer. The JBI Checklist for cohort studies was used as an additional level of screening. Consensus was required for exclusion reasons and any conflicts were resolved by a third independent reviewer.

Risk of Reinfection From SARS-CoV-2 – An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review

Introduction The healthcare field is struggling with urgent questions about how to respond to the current COVID-19 pandemic. Health systems, clinicians, policymakers, and the general public want evidence to inform critical decisions. 

Irina Arkhipova-Jenkins

Papers

His-bundle pacing versus biventricular pacing in cardiac resynchronization therapy patients: A crossover design comparison.

Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection

Risk of Reinfection From SARS-CoV-2 – An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review

Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review